Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Cyclophosphamide
Therapeutic Area : Oncology
Study Phase : Approved
Sponsor : Dr. Reddy\'s Laboratories
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Dr Reddy's Signs In-Licensing Pact with Ingenus for Cancer Treatment Injection
Details : Under the in-licensing pact, Dr Reddy's USA will commercialise the Cyclophosphamide injection, an alkylating drug indicated for treatment of malignant lymphomas, for the US market.
Brand Name : Cyclophosphamide-Generic
Molecule Type : Small molecule
Upfront Cash : Undisclosed
June 12, 2024
Lead Product(s) : Cyclophosphamide
Therapeutic Area : Oncology
Highest Development Status : Approved
Sponsor : Dr. Reddy\'s Laboratories
Deal Size : Undisclosed
Deal Type : Licensing Agreement
LOOKING FOR A SUPPLIER?
Reset All
